Envoy Medical Ownership | Who Owns Envoy Medical?
Envoy Medical Ownership Summary
Envoy Medical is owned by 4.89% institutional investors, 36.89% insiders, and 58.22% retail investors. Vanguard group is the largest institutional shareholder, holding 1.77% of COCH shares.
COCH Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Envoy Medical | 4.89% | 36.89% | 58.22% |
| Sector | Healthcare Stocks | 232.20% | 10.74% | -142.94% |
| Industry | Medical Device Stocks | 37.54% | 10.61% | 51.85% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 347.30K | 1.77% | $229.56K |
| Weiss asset management lp | 242.64K | 1.13% | $188.22K |
| Colony group | 212.66K | 0.99% | $164.96K |
| Arcus capital partners | 152.87K | 0.71% | $118.58K |
| Geode capital management | 98.35K | 0.50% | $65.04K |
| Cibc private wealth group | 77.89K | 0.40% | $51.49K |
| Morgan stanley | 57.10K | 0.29% | $37.75K |
| Blackrock funding, inc. /de | 39.91K | 0.20% | $26.38K |
| Ci private wealth | 38.16K | 0.18% | $29.60K |
| Lpl financial | 28.40K | 0.14% | $18.78K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Arcus capital partners | 152.87K | 0.05% | $118.58K |
| Ballew advisors | 10.12K | 0.00% | $6.94K |
| Weiss asset management lp | 242.64K | 0.00% | $188.22K |
| Bluestem wealth partners | 10.45K | 0.00% | $6.91K |
| American capital advisory | 2.00K | 0.00% | $1.32K |
| Virtu financial | 13.89K | 0.00% | $11.00K |
| Fortitude family office | 1.98K | 0.00% | $1.31K |
| Colony group | 212.66K | 0.00% | $164.96K |
| Cibc private wealth group | 77.89K | 0.00% | $51.49K |
| Tower research capital llc (trc) | 4.11K | 0.00% | $3.19K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Geode capital management | 98.35K | - | 51.81K |
| Blackrock funding, inc. /de | 39.91K | - | 16.49K |
| Virtu financial | 13.89K | 0.00% | 13.89K |
| Northern trust | 26.39K | - | 12.35K |
| Vanguard group | 347.30K | - | 8.19K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Northrock partners | - | - | -10.29M |
| Atlas merchant capital | - | - | -555.53K |
| Dsg capital advisors | - | - | -163.64K |
| Weiss asset management lp | 242.64K | 0.00% | -125.50K |
| Highpoint advisor group | - | - | -38.66K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Virtu financial | 13.89K | 0.00% | 13.89K | $11.00K |
| Fortitude family office | 1.98K | 0.00% | 1.98K | $1.31K |
Sold Out
| Holder | Change |
|---|---|
| Sbi securities | -1.00 |
| Jpmorgan chase | -19.00 |
| Barclays | -203.00 |
| Highpoint advisor group | -38.66K |
| Dsg capital advisors | -163.64K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 17 | -41.38% | 959,196 | -56.43% | 4 | 4.62% | 7 | -41.67% | 2 | -66.67% |
| Sep 30, 2025 | 27 | 17.39% | 2,096,162 | -83.36% | 9 | 0.28% | 11 | 175.00% | 6 | 20.00% |
| Jun 30, 2025 | 23 | 4.55% | 12,596,501 | 446.87% | 58 | 50.50% | 4 | -42.86% | 5 | 25.00% |
| Mar 31, 2025 | 22 | -12.00% | 2,303,397 | 13.74% | 10 | 9.30% | 7 | -46.15% | 4 | 100.00% |
| Dec 31, 2024 | 25 | 38.89% | 2,025,076 | 96.05% | 10 | 38.87% | 13 | 62.50% | 2 | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 12, 2026 | Patel Mona Chetan | - | Buy | $75.00K |
| Feb 12, 2026 | Patel Mona Chetan | - | Buy | $125.00K |
| Feb 12, 2026 | Patel Mona Chetan | - | Buy | $125.00K |
| Feb 12, 2026 | Potashnick Robert | Interim CFO | Buy | $85.00K |
| Feb 12, 2026 | Potashnick Robert | Interim CFO | Buy | $85.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2027 Q4 | - | - |
| 2024 Q3 | 2 | - |
| 2024 Q2 | - | - |
| 2024 Q1 | 1 | - |
| 2023 Q4 | 3 | - |
COCH Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools